Daxor EBIT 2010-2011 | DXR

Daxor ebit from 2010 to 2011. Ebit can be defined as earnings before interest and taxes.
Daxor Annual EBIT
(Millions of US $)
2011 $-6
2010 $-6
2009 $-5
Daxor Quarterly EBIT
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-1
2011-06-30 $-1
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-1
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-1
2009-06-30 $-1
2009-03-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.052B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.544B 19.63
Encompass Health (EHC) United States $12.432B 24.83
DaVita (DVA) United States $9.837B 14.07
Elanco Animal Health (ELAN) United States $8.689B 19.43
Chemed (CHE) United States $6.617B 22.16
RadNet (RDNT) United States $5.277B 190.58
Option Care Health (OPCH) United States $4.518B 19.33
LifeStance Health (LFST) United States $2.139B 0.00
Addus HomeCare (ADUS) United States $2.102B 22.66
Astrana Health (ASTH) United States $1.680B 58.76
Aveanna Healthcare Holdings (AVAH) United States $1.471B 27.08
U.S Physical Therapy (USPH) United States $1.284B 32.12
Atai Life Sciences (ATAI) Germany $0.941B 0.00
Pennant (PNTG) United States $0.855B 30.18
MEDIROM Healthcare Technologies (MRM) Japan $0.049B 0.00
Psychemedics (PMD) United States $0.000B 0.00